Increase in elderly population, high-end technological advancements in medical technology for donor screening, and enhancements in blood transfusion instruments are the major factors propelling the growth of the global blood market.
According to the report, the global blood market was estimated at $33.50 billion in 2016 and is expected to reach $45.98 Billion by 2023, garnering a CAGR of 4.6% during the forecast period. The report offers a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
Rise in geriatric population, technological advancements in medical technology for donor screening, and improvements in blood transfusion instruments drive the growth of the global blood market. On the other hand, progress in minimal invasive technology restrains the growth to certain extent. However, enhancement in healthcare facilities in the Asia-Pacific region is projected to create an array of lucrative opportunities in the industry.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/2297
The report divides the market into product, end user, and geography. Based on product, the market is categorized into Whole Blood Collection, Source Plasma Collections, Blood Therapeutics, Blood Typing Products, Blood Screening, and Blood Processing Equipment & Associated Products. Based on end-user, the market is classified into Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals and Others (Academic Institutes & Research Laboratories). Based on region, the market is analyzed across North America, Mexico, Rest of Europe and LAMEA.
By product, the blood therapeutics segment contributed to the the major share in 2016 and is expected to rule the roost during 2017–2023. By end-user, the blood & blood component bank segment is anticipated to cite the fastest CAGR of 4.9% by 2023. By geography, the region across North America would grow at a CAGR of 4.4% throughout the estimated period.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/2297
Scope Of The Report
|Market size available for years||2017-2023|
|Base year considered||2016|
|Forecast units||Value (USD)|
|Segments covered||By Product, End-user and By Geography|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
The key players analyzed in the report include Baxter International Inc., Becton, Dickinson & Co., Grifols International SA., Ortho Clinical Diagnostics, Immucor, Novartis, Abbott Laboratories, Novo Nordisk, Roche Diagnostics, and CSL Behring. These players have incorporated different strategies including expansions, mergers & acquisitions, partnerships, joint ventures, collaborations, and others to heighten their stand in the market.
Self-Monitoring Blood Glucose Devices Market by Product (Test Strips, Lancets, and Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes), and End User (Hospitals, Home Settings, and Diagnostic Centers) – Global Opportunity Analysis and Industry Forecast, 2018-2025
Blood Plasma Derivatives Market by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, and Others), Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, von Willebrands Disease (vWD), and Other Application), and End User (Hospitals, Clinics, and Other End Users) – Global Opportunity Analysis and Industry Forecast, 2016-2023
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht